These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35865857)

  • 1. [Association between depression and viral load in people on antiretroviral treatment followed at the Yaoundé Central Hospital in Cameroon].
    Voundi EV; Kalla GCM; Kenfack JDT; Olen JPK; Essi MJ; Mbopi-Keou FX
    Pan Afr Med J; 2022; 41():320. PubMed ID: 35865857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of oral candidiasis according to antiretroviral treatment status, immunological and virological profiles among HIV infected patients in two health facilities in Yaoundé-Cameroon: a cross-sectional and analytical study.
    Fokam J; Nka AD; Semengue ENJ; Asso'o CKE; Gabisa JE; Ka'e AC; Bouba Y; Pabo W; Geh BKN; Gouissi D; Chenwi CA; Tchouaket MCT; Abba A; Takou D; Fainguem N; Kamgaing RS; Sosso SM; Abena MEN; Ndjolo A
    Pan Afr Med J; 2023; 45():33. PubMed ID: 37545607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé.
    Nka AD; Sosso SM; Fokam J; Bouba Y; Teto G; Simo Rachel R; Tiga A; Yimga J; Nukenine EN; Nanfack AJ; Takou D; Aroga Z; Colizzi V; Ndjolo A
    BMC Res Notes; 2019 Sep; 12(1):632. PubMed ID: 31554515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of "test and treat".
    Fokam J; Sosso SM; Yagai B; Billong SC; Djubgang Mbadie RE; Kamgaing Simo R; Edimo SV; Nka AD; Tiga Ayissi A; Yimga JF; Takou D; Moudourou S; Ngo Nemb M; Nfetam Elat JB; Santoro MM; Perno CF; Colizzi V; Ndjolo A
    AIDS Res Ther; 2019 Nov; 16(1):36. PubMed ID: 31744517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon.
    Njom-Nlend AE; Efouba N; Brunelle Sandie A; Fokam J
    Trop Med Int Health; 2021 Aug; 26(8):927-935. PubMed ID: 33905593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon.
    Aghokeng AF; Kouanfack C; Eymard-Duvernay S; Butel C; Edoul GE; Laurent C; Koulla-Shiro S; Delaporte E; Mpoudi-Ngole E; Peeters M
    J Int AIDS Soc; 2013 Jan; 16(1):18004. PubMed ID: 23374858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First line antiretroviral treatment failure and associated factors among people living with HIV in northwest Ethiopia.
    Genet A; Mekonnen Z; Yizengaw E; Mekonnen D
    Afr Health Sci; 2021 Mar; 21(1):263-272. PubMed ID: 34394306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon.
    Gaynes BN; Pence BW; Atashili J; O'Donnell JK; Njamnshi AK; Tabenyang ME; Arrey CK; Whetten R; Whetten K; Ndumbe P
    PLoS One; 2015; 10(10):e0140001. PubMed ID: 26469186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon.
    Fokam J; Geh BKN; Sosso SM; Takou D; Ngufack ES; Nka AD; Bissek AZ; Eko DM; Ndjolo A
    BMC Oral Health; 2020 Dec; 20(1):359. PubMed ID: 33308188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon.
    Fokam J; Billong SC; Jogue F; Moyo Tetang Ndiang S; Nga Motaze AC; Paul KN; Njom Nlend AE
    PLoS One; 2017; 12(11):e0187566. PubMed ID: 29112991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of the psychomotor development delay in children aged 12 to 59 months infected with HIV in Yaounde, Cameroon.
    Kalla GCM; Dongmo ULT; Assob JCN; Noubi NK; Mbopi-Keou FX; Monebenimp F
    Pan Afr Med J; 2022; 42():114. PubMed ID: 36034046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaoundé, Cameroon.
    Sosso SM; Tchouaket MCT; Fokam J; Simo RK; Torimiro J; Tiga A; Lobe EE; Ambada G; Nange A; Semengue ENJ; Nka AD; Tala V; Chenwi C; Abba A; Ka'e AC; Yagai B; Colizzi V; Ndjolo A
    Virol J; 2020 May; 17(1):69. PubMed ID: 32430034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.
    Hailu GG; Wasihun AG
    BMC Infect Dis; 2021 Jun; 21(1):561. PubMed ID: 34118891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression management and antiretroviral treatment outcome among people living with HIV in Northwest and East regions of Cameroon.
    Ndenkeh JJN; Nji AM; Yumo HA; Rothe C; Kroidl A
    BMC Infect Dis; 2022 Sep; 22(1):732. PubMed ID: 36100890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correlates of depressive symptoms in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon.
    L'akoa RM; Noubiap JJ; Fang Y; Ntone FE; Kuaban C
    BMC Psychiatry; 2013 Sep; 13():228. PubMed ID: 24053612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings.
    Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A
    BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
    Liégeois F; Boyer S; Eymard-Duvernay S; Carrieri P; Kouanfack C; Domyeum J; Maradan G; Ducos J; Mpoudi-Ngolé E; Spire B; Delaporte E; Kuaban C; Vidal L; Laurent C;
    BMC Infect Dis; 2020 Jan; 20(1):49. PubMed ID: 31941464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM).
    Liégeois F; Eymard-Duvernay S; Boyer S; Maradan G; Kouanfack C; Domyeum J; Boyer V; Mpoudi-Ngolé E; Spire B; Delaporte E; Vidal L; Kuaban C; Laurent C;
    HIV Med; 2019 Jan; 20(1):38-46. PubMed ID: 30362279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of community-based organizations in the improvement of Joint United Nations Program on HIV and AIDS 90-90-90: case of the Yaoundé Central Hospital.
    Kouanfack C; Mvilongo M; Zemsi S; Fomete L; Mapa-Tassou C; Djam A; Zambou F; Ateudjieu J; Fouda PJ
    Pan Afr Med J; 2023; 45():173. PubMed ID: 37954437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects.
    Fonsah JY; Njamnshi AK; Kouanfack C; Qiu F; Njamnshi DM; Tagny CT; Nchindap E; Kenmogne L; Mbanya D; Heaton R; Kanmogne GD
    PLoS One; 2017; 12(1):e0170893. PubMed ID: 28141867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.